- C22.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C22.0 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C22.0 – other international versions of ICD-10 C22.0 may differ.
ICD-10-CM C22.0 is grouped within Diagnostic Related Group(s):
- 435 Malignancy of hepatobiliary system or pancreas with mcc
- 436 Malignancy of hepatobiliary system or pancreas with cc
- 437 Malignancy of hepatobiliary system or pancreas without cc/mcc
Applicable To
- Hepatocellular carcinoma
- Hepatoma
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C22.0:
- hepatocellular > Cancer
- bile duct > Carcinoma (malignant)
- with hepatocellular, mixed > bile duct C22.0
- hepatic cell > Carcinoma (malignant)
- hepatocellular > Carcinoma (malignant)
- with bile duct, mixed > hepatocellular C22.0
- fibrolamellar > hepatocellular C22.0
- hepatocholangiolitic > Carcinoma (malignant)
- liver cell > Carcinoma (malignant)
- with hepatocellular carcinoma, combined > Cholangiocarcinoma
- liver > Embryoma
- liver > malignant C64.-
- embryonal > Hepatoma (malignant) C22.0